Novel inhaled anti-inflammatory drugs and inhaled monoclonal antibodies

P. Rogliani (Roma (RM), Italy)

Source: International Congress 2022 – The future of inhalation therapy in COPD

Session: The future of inhalation therapy in COPD
Session type: Hot topics
Number: 1468

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Rogliani (Roma (RM), Italy). Novel inhaled anti-inflammatory drugs and inhaled monoclonal antibodies. International Congress 2022 – The future of inhalation therapy in COPD

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.